Vasella talks trends in interview

In an interview with McKinsey Quarterly, Novartis CEO Daniel Vasella identifies aging, prescription drug costs and the shift of economic power as "mega-trends" that will impact the pharma industry's future. The wide-ranging article also covers the CEO's thoughts on his management style, healthcare reform, executive compensation and more. Interview

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.